Company
Every investor coverage indicates participated in a round Alpine Bio raised.
Companies Alpine Bio acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Alpine Bio. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Interview with Eclipse Ingredients' chief executive on commercialising human lactoferrin through precision fermentation, beginning with cosmetics, plus its distributor agreements and partnerships for manufacturing scale-up.
Precision fermentation startup All G banked A$10 million through a convertible note and teamed up with French dairy ingredients maker Armor Protéines to sell lactoferrin, targeting a first product launch in early 2026.